Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Pure and Applied Chemistry

The Scientific Journal of IUPAC

Ed. by Burrows, Hugh / Stohner, Jürgen


IMPACT FACTOR 2018: 2.350
5-year IMPACT FACTOR: 4.037

CiteScore 2018: 4.66

SCImago Journal Rank (SJR) 2018: 1.240
Source Normalized Impact per Paper (SNIP) 2018: 1.826

Online
ISSN
1365-3075
See all formats and pricing
More options …
Volume 91, Issue 7

Issues

Novel dodecyl-containing azido and glucuronamide-based nucleosides exhibiting anticancer potential

Nuno M. Xavier
  • Corresponding author
  • Centro de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Ed. C8, 2°/5° Piso, Campo Grande, 1749-016 Lisboa, Portugal
  • Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rita Goncalves-Pereira
  • Centro de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Ed. C8, 2°/5° Piso, Campo Grande, 1749-016 Lisboa, Portugal
  • Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Radek Jorda
  • Corresponding author
  • Laboratory of Growth Regulators, Centre of the Region Hana for Biotechnological and Agricultural Research, Palacky University and Institute of Experimental Botany, the Czech Academy of Sciences, Šlechtitelů 27, 78371 Olomouc, Czech Republic
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Denisa Hendrychová
  • Laboratory of Growth Regulators, Centre of the Region Hana for Biotechnological and Agricultural Research, Palacky University and Institute of Experimental Botany, the Czech Academy of Sciences, Šlechtitelů 27, 78371 Olomouc, Czech Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ M. Conceição Oliveira
  • Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-04-15 | DOI: https://doi.org/10.1515/pac-2019-0106

Abstract

The synthesis and anticancer evaluation of new series of nucleosides constructed on 5/6-azidoglycosyl or glucuronamide moieties and containing an O- or an N-dodecyl chain, respectively, are disclosed. Based on our previous results, their structures were planned to preclude them to act via a similar metabolic pathway than that of clinically used nucleoside antimetabolites, against which cancer cells frequently acquire resistance. Xylo and gluco-configured 5/6-azido-1,2-di-O-acetyl furanosyl and pyranosyl donors containing a 3-O-dodecyl group were synthesized from diacetone-d-glucose and were subsequently coupled with silylated uracil or 2-acetamido-6-chloropurine. N-Dodecyl glucuronamide-based nucleosides were accessed from acetonide-protected glucofuranurono-6,3-lactone, which was converted in few steps into O-benzylated 1,2-di-O-acetyl furanuronamide or pyranuronamide derivatives to undergo further N-glycosylation. Both types of nucleosides demonstrated notorious antiproliferative effects in chronic myeloid leukemia (K562) and in breast cancer (MCF-7) cells. The most potent molecules were a 6ʹ-azidoglucopyranosyl N7-linked purine nucleoside and glucofuranuronamide derivatives comprising N1-linked uracil and N7-linked purine units with activities in the single-digit micromolar order of concentration against both cell lines. Their GI50 values in MCF-7 cells were similar or ca. 3-fold lower than that of the standard drug 5-fluorouracil. Cell cycle studies and immunoblotting analysis of apoptosis-associated proteins in treated K562 cells indicated that the antiproliferative effect of the most effective nucleosides is based on apoptosis induction.

Keywords: anticancer activity; apoptosis; azido nucleosides; glucuronamide-based nucleosides; ICS-29; nucleoside analogs

Article note

A collection of invited papers based on presentations at the 29th International Carbohydrate Symposium (ICS-29), held in the University of Lisbon, Portugal, 14–19 July 2018.

References

  • [1]

    J. Shelton, X. Lu, J. A. Hollenbaugh, J. H. Cho, F. Amblard, R. F. Schinazi. Chem. Rev. 116, 14379 (2016).CrossrefGoogle Scholar

  • [2]

    L. P. Jordheim, D. Durantel, F. Zoulim, C. Dumontet. Nat. Rev. Drug Discov. 12, 447 (2013).CrossrefGoogle Scholar

  • [3]

    W. B. Parker. Chem. Rev. 109, 2880 (2009).CrossrefGoogle Scholar

  • [4]

    F. Ricci, A. Tedeschi, E. Morra, M. Montillo. Ther. Clin. Risk Manag. 5, 187 (2009).Google Scholar

  • [5]

    A. Zhenchuk, K. Lotfi, G. Juliusson, F. Albertioni. Biochem. Pharmacol. 78, 1351 (2009).CrossrefGoogle Scholar

  • [6]

    W. B. Parker, A. R. Bapat, J. X. Shen, A. J. Townsend, Y. C. Cheng. Mol. Pharmacol. 34, 485 (1988).Google Scholar

  • [7]

    S. Noble, K. L. Goa. Drugs 54, 447 (1997).CrossrefGoogle Scholar

  • [8]

    L. de Sousa Cavalcante, G. Monteiro. Eur. J. Pharmacol. 741, 8 (2014).CrossrefGoogle Scholar

  • [9]

    N. Suzuki, T. Emura, M. Fukushima. Int. J. Oncol. 39, 263 (2011).Google Scholar

  • [10]

    C. M. Galmarini, J. R. Mackey, C. Dumontet. Leukemia 15, 875 (2001).CrossrefGoogle Scholar

  • [11]

    Y. Jia, J. Xie. Genes Dis. 2, 299 (2015).CrossrefGoogle Scholar

  • [12]

    A. M. Fajardo, G. A. Piazza, H. N. Tinsley. Cancers 6, 436 (2014).CrossrefGoogle Scholar

  • [13]

    K. Bian, F. Murad. Adv. Exp. Med. Biol. 814, 5 (2014).CrossrefGoogle Scholar

  • [14]

    T. Regad. Cancers 7, 1758 (2015).CrossrefGoogle Scholar

  • [15]

    P. Liu, H. Cheng, T. M. Roberts, J. J. Zhao. Nat. Rev. Drug Discov. 8, 627 (2009).CrossrefGoogle Scholar

  • [16]

    C. Porta, C. Paglino, A. Mosca. Front. Oncol. 4, 1 (2014).Google Scholar

  • [17]

    S. Lapenna, A. Giordano. Nat. Rev. Drug Discov. 8, 547 (2009).CrossrefGoogle Scholar

  • [18]

    M. Aarts, S. Linardopoulos, N. C. Turner. Curr. Opin. Pharmacol. 13, 529 (2013).CrossrefGoogle Scholar

  • [19]

    U. Asghar, A. K. Witkiewicz, N. C. Turner, E. S. Knudsen. Nat. Rev. Drug Discov. 14, 130 (2015).CrossrefGoogle Scholar

  • [20]

    K. R. Kelly, J. Ecsedy, D. Mahalingam, S. T. Nawrocki, S. Padmanabhan, F. J. Giles, J. S. Carew. Curr. Drug Targets 12, 2067 (2011).CrossrefGoogle Scholar

  • [21]

    X. Liu. Transl. Oncol. 8, 185 (2015).CrossrefGoogle Scholar

  • [22]

    N. M. Xavier, R. Gonçalves-Pereira, R. Jorda, E. Řezníčková, V. Kryštof, M. C. Oliveira. Pure Appl. Chem. 89, 1267 (2017).CrossrefGoogle Scholar

  • [23]

    N. M. Xavier, A. Porcheron, D. Batista, R. Jorda, E. Řezníčková, V. Kryštof, M. C. Oliveira. Org. Biomol. Chem. 15, 4667 (2017).CrossrefGoogle Scholar

  • [24]

    D. R. McIlwain, T. Berger, T. W. Mak. Cold Spring Harb. Perspect. Biol. 5, a008656 (2013)Google Scholar

  • [25]

    C. Holohan, S. Van Schaeybroeck, D. B. Longley, P. G. Johnston. Nat. Rev. Cancer 13, 714 (2013).CrossrefGoogle Scholar

  • [26]

    R. Rathore, J. E. McCallum, E. Varghese, A. -M. Florea, D. Büsselberg. Apoptosis 22, 898 (2017).CrossrefGoogle Scholar

  • [27]

    C. D. DiNardo, S. O’Brien, V. V. Gandhi, F. Ravandi. Future Oncol. 9, 1073 (2013).CrossrefGoogle Scholar

  • [28]

    M. Norkin, A. I. Richards. Expert Rev. Anticancer Ther. 15, 1261 (2015).CrossrefGoogle Scholar

  • [29]

    M. Brandl, X. Wu, M. Holper, L. Hong, Z. Jia, R. Birudaraj, M. Reddy, T. Alfredson, T. Tran, S. Larrabee, X. Hadig, K. Sarma, C. Washington, G. Hill, D. B. Smith. Drug Devel. Ind. Pharm. 34, 683 (2008).CrossrefGoogle Scholar

  • [30]

    S. K. Roberts, G. Cooksley, G. J. Dore, R. Robson, D. Shaw, H. Berns, G. Hill, K. Klumpp, I. Najera, C. Washington. Hepatology 48, 398 (2008).CrossrefGoogle Scholar

  • [31]

    M. R. Mish, A. Cho, T. Kirschberg, J. Xu, C. S. Zonte, M. Fenaux, Y. Park, D. Babusis, J. Y. Feng, A. S. Ray, C. U. Kim. Bioorg. Med. Chem. Lett. 24, 3092 (2014).CrossrefGoogle Scholar

  • [32]

    Z. J. Witczak. “Recent advances in the synthesis of functionalized carbohydrate azides”, in Specialist Periodical Reports: Carbohydrate Chemistry, A. P. Rauter, T. Lindhorst (Eds.), Vol. 36, pp. 176–193, Royal Society of Chemistry, London (2010).Web of ScienceGoogle Scholar

  • [33]

    H. S. G. Beckmann, V. Wittmann. “Azides in carbohydrate chemistry”, in Organic Azides: Syntheses and Applications, S. Bräse, K. Banert (Eds.), Vol. 16, pp. 469–490, John Wiley & Sons, Ltd, Chichester (2010).Google Scholar

  • [34]

    S. Schwarz, B. Siewert, R. Csuk, A. P. Rauter. Eur. J. Med. Chem. 90, 592 (2015).Google Scholar

  • [35]

    R. Gonçalves-Pereira, M. P. Pereira, S. G. Serra, A. Loesche, R. Csuk, S. Silvestre, P. J. Costa, M. C. Oliveira, N. M. Xavier. Eur. J. Org. Chem. 2018, 2667 (2018).CrossrefGoogle Scholar

  • [36]

    C. Soldani, A. I. Scovassi. Apoptosis 7, 321 (2002).CrossrefGoogle Scholar

  • [37]

    M. P. Huestis, G. A. Aish, J. P. M. Hui, E. C. Soob, D. L. Jakeman. Org. Biomol. Chem. 6, 477 (2008).CrossrefGoogle Scholar

About the article

Published Online: 2019-04-15

Published in Print: 2019-07-26


Funding Source: FCT Investigator Program to N.M.X

Award identifier / Grant number: IF/01488/2013

Funding Source: Palacký University in Olomouc

Award identifier / Grant number: IGA_PrF_2018_006

‘Fundação para a Ciência e Tecnologia’ (FCT) is acknowledged for funding through the FCT Investigator Program to N.M.X. (Funder Id: http://dx.doi.org/10.13039/501100001871, IF/01488/2013), the exploratory project IF/01488/2013/CP1159/CT0006 and the strategic project UID/MULTI/00612/2013. RJ and DH gratefully acknowledge support from the Ministry of Education, Youth and Sports of the Czech Republic (OP VVV Excellent research ENOCH, CZ.02.1.01/0.0/0.0/16_019/0000868) and from Palacký University in Olomouc (Funder Id: http://dx.doi.org/10.13039/501100007059, IGA_PrF_2018_006).


Citation Information: Pure and Applied Chemistry, Volume 91, Issue 7, Pages 1085–1105, ISSN (Online) 1365-3075, ISSN (Print) 0033-4545, DOI: https://doi.org/10.1515/pac-2019-0106.

Export Citation

©2019 IUPAC & De Gruyter. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. For more information, please visit: http://creativecommons.org/licenses/by-nc-nd/4.0/.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Nuno M. Xavier, Eduardo C. de Sousa, Margarida P. Pereira, Anne Loesche, Immo Serbian, René Csuk, and M. Conceição Oliveira
Pharmaceuticals, 2019, Volume 12, Number 3, Page 103

Comments (0)

Please log in or register to comment.
Log in